MCRB- Seres Therapeutics, Inc.

Name: Seres Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Seres Therapeutics, Inc. (MCRB) has 9 insiders with recent SEC Form 4 filings, including 2 buys and 11 sells. MCRB is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Brady Kelly	56.3K	$369.6K	-
Other	Desrosier Thomas	22.5K	$147.8K	-
Dir	Berenson Stephen	11.5K	$75.4K	-
Dir	Shaff Eric D.	11.0K	$72.3K	-
Dir	Rosiello Robert L.	10.0K	$65.7K	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Oct 30, 2023	Arkowitz David61	Chief Financial Officer	Sale+OE	4,066	$1.35	$5,489.10	-2.3%	-13.8%	-46.8%
Oct 30, 2023	Desrosier Thomas66	Chief Legal Officer And EVP	Sale+OE	4,156	$1.35	$5,610.60	-3.5%	-13.8%	-46.8%
Oct 30, 2023	Ege David S.80	See Remarks	Sale+OE	4,066	$1.35	$5,489.10	-5.7%	-13.8%	-46.8%
Oct 30, 2023	Von Moltke Lisa65	See Remarks	Sale+OE	4,232	$1.35	$5,713.20	-30.8%	-13.8%	-46.8%
Oct 30, 2023	Henn Matthew R.66	See Remarks	Sale+OE	3,886	$1.35	$5,246.10	-6.5%	-13.8%	-46.8%
Apr 28, 2023	Ege David S.80	See Remarks	Sell	7,038	$5.19	$36,527.22	-10.5%	-9.3%	-83.1%
Oct 31, 2022	Ege David S.80	See Remarks	Sell	5,012	$7.93	$39,745.16	-9.7%	-38.4%	-82.7%
Jul 5, 2022	Nutritional Health Ltp Fund General Partner LLC	10% Owner	Buy	8,738,243	$3.15	$27,525,465.45	+294.9%	+61.6%	+24.3%
Dec 1, 2020	Henn Matthew R.66	See Remarks	Sale+OE	91,812	$27.04	$2,482,308.70	-66.6%	-	-
Nov 22, 2019	Chapman Marcus	See Remarks	Sale+OE	3,400	$3.91	$13,296.72	-28.3%	-	-

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC